Clinical Trial

Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at Onset

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The clinical implication of this study lies in the identification of factors that may predict reduced insulin sensitivity in children and adolescents at the onset of Type 1 Diabetes and would help the physician to undertake appropriate therapy more quickly by achieving the correct therapeutic dosage, in order to achieve good metabolic compensation at an early stage and thus reduce the time (and costs) of hospitalisation.
Trial Details
NCT Number NCT06717893
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Type 1 Diabetes (T1D)
Enrollment 180 participants
Start Date 2020-10-09
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-05